Top Healthcare Innovations Reshaping Oral Solid Dosage Contract Manufacturing According to a newly published market research report by 24LifeSciences, global oral solid dosage contract manufacturing market is valued at USD 75.5 billion in 2026 and is projected to reach USD 117.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. Oral solid dosage (OSD) contract manufacturing involves outsourcing the production of solid-form pharmaceuticals, such as tablets, capsules, powders, and granules, to specialized third-party organizations. This business model allows pharmaceutical companies to leverage external expertise, advanced technologies, and scalable production capacity without major capital investment, which is crucial for managing the complex and regulated process of drug development and commercialization. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8832/oral-solid-dosage-contract-manufacturing-market

Next Generation Cancer Diagnostics Market: Innovation-Driven Growth and Future Opportunities According to a newly published market research report by 24LifeSciences, global next generation cancer diagnostics market was valued at USD 8,060 million in 2026 and is projected to reach USD 28,120 million by 2034, growing at a compound annual growth rate (CAGR) of 20.0% during the forecast period. Next generation cancer diagnostics represent a paradigm shift from traditional histopathology. These advanced technologies enable highly sensitive and specific analysis of cancer biomarkers from various biological samples, with key platforms including Next Generation Sequencing (NGS), qPCR & Multiplexing, and DNA Microarrays. These tools are fundamental for applications such as early detection, companion diagnostics, treatment selection, and minimal residual disease monitoring, enabling a more precise and personalized approach to oncology. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8895/next-generation-cancer-diagnostics-market

What Is the Future of the Surgical Scalpel Market? Growth Forecasts & Insights According to a newly published market research report by 24LifeSciences, global surgical scalpel market was valued at USD 289 million in 2026 and is projected to reach USD 392 million by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period. The surgical scalpel represents one of the most fundamental and essential instruments in modern medicine, serving as the primary cutting tool across countless surgical procedures. These precision instruments are categorized into disposable single-use systems and reusable handles with replaceable blades, each designed to meet specific clinical needs for sterility, precision, and safety. The consistent and indispensable role of scalpels in operating rooms, emergency departments, and outpatient clinics worldwide underpins steady market demand. Growth is largely sustained by the ever-present volume of surgical interventions, making this a resilient and essential segment within the broader surgical instrument landscape. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7324/surgical-scalpel-market

Leading Players Driving Growth in the Global Cell Detachment and Dissociation Solution Market According to a newly published market research report by 24LifeSciences, global cell detachment and dissociation solution market is valued at USD 547.8 million in 2026 and is projected to reach USD 882.4 million by 2034, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period. Cell detachment and dissociation solutions are essential reagents in cell culture workflows, designed to effectively separate adherent cells from culture surfaces and dissociate them into viable single-cell suspensions. These solutions are critically important for numerous applications including cell harvesting, subculturing, cell-based assays, flow cytometry, and bioproduction processes. The market is primarily categorized into enzyme-based solutions such as trypsin and collagenase, and non-enzymatic alternatives that utilize chelating agents, each offering distinct advantages for specific cell types and research requirements. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9791/cell-detachment-and-dissociation-solution-market

Surface Plasmon Resonance Systems: Advancing Label-Free Detection According to a newly published market research report by 24LifeSciences, global Surface Plasmon Resonance (SPR) System market was valued at USD 820 million in 2026 and is projected to reach USD 1.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. Surface Plasmon Resonance (SPR) is a label-free, real-time optical biosensing technology that enables detailed analysis of biomolecular interactions by detecting changes in refractive index on a sensor surface. This technology provides critical insights into binding kinetics, affinity, and specificity without requiring fluorescent or radioactive labels, making it invaluable across multiple scientific disciplines. Its ability to characterize molecular interactions with exceptional precision continues to drive its adoption in pharmaceutical research, diagnostics development, and academic studies. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10057/surface-plasmon-resonance-spr-system-market

Why Humanized Liver Mouse Models Are Critical for Drug Metabolism Studies According to a newly published market research report by 24LifeSciences, global humanized liver mice models market was valued at USD 129.4 million in 2026 and is projected to reach USD 225.7 million by 2034, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period. Humanized liver mice models are advanced in vivo research tools created by engrafting functional human hepatocytes into immunodeficient mice. These models are indispensable for studying human-specific liver diseases, drug metabolism, pharmacokinetics, and toxicity profiles because they replicate critical aspects of human liver function, including the expression of cytochrome P450 enzymes and susceptibility to human-tropic pathogens like Hepatitis B and C viruses. Their ability to provide human-relevant data makes them superior to conventional animal models for predicting drug behavior in humans. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9194/humanized-liver-mice-models-market

What Is the Future of the Osgood-Schlatter Market? Key Insights & Growth Outlook According to a newly published market research report by 24LifeSciences, global Osgood-Schlatter disease management market was valued at USD 2,774 million in 2024 and is projected to reach USD 3,282 million by 2032, growing at a compound annual growth rate (CAGR) of 2.5% during the forecast period 2025–2032. Osgood-Schlatter disease (OSD) is a common condition classified as a traction apophysitis of the tibial tuberosity. This essentially means it is an overuse injury causing inflammation at the point where the patellar tendon attaches to the growing tibia bone. The primary manifestations include a painful lump below the kneecap, with symptoms typically worsening during physical activity and improving with rest. This condition predominantly affects adolescents during growth spurts, with epidemiological studies indicating it affects approximately 4% of the adolescent population. Its management is crucial within pediatric orthopedics and sports medicine, focusing on pain relief and maintaining mobility during a critical developmental period. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9569/osgood-schlatter-market

Top 10 Key Players Transforming the Quaternary Ammonium Salts Disinfectant Market According to a newly published market research report by 24LifeSciences, global quaternary ammonium salts disinfectant market value is at USD 1.5 billion in 2026 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period. Quaternary ammonium compounds, commonly known as quats, are a class of positively charged antimicrobial agents widely recognized for their effective disinfection properties. They function by disrupting the cell membranes of microorganisms, leading to the inactivation of a broad spectrum of pathogens, including bacteria, enveloped viruses, and fungi. Their efficacy, combined with relatively low toxicity and stability, makes them a fundamental component in infection control protocols across healthcare, food processing, and institutional cleaning sectors. The lasting emphasis on hygiene, accelerated by the COVID-19 pandemic, continues to drive their adoption and innovation. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10348/quaternary-ammonium-salts-disinfectant-market

Global Microarray Analysis Market Trends: Genomics Research Driving Market Expansion According to a newly published market research report by 24LifeSciences, global microarray analysis market value is at USD 2.58 billion in 2026 and is projected to reach USD 4.02 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period. A microarray is a multiplex lab-on-a-chip that represents a foundational high-throughput technology in genomics and proteomics. These platforms consist of a two-dimensional array on a solid substrate, such as a glass slide, which enables the parallel analysis of thousands of biological elements simultaneously. The core technology, first introduced for antibody microarrays by Tse Wen Chang in 1983, facilitates miniaturized and multiplexed processing for applications like gene expression profiling, genotyping, and biomarker discovery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9533/microarray-analysis-market

Rising GI Disorders Driving the Malabsorption Syndrome Market Worldwide According to a newly published market research report by 24LifeSciences, global malabsorption syndrome market value is at USD 8.5 billion in 2026 and is projected to reach USD 13.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period. Malabsorption syndrome encompasses a group of disorders where the small intestine is unable to properly absorb sufficient amounts of critical nutrients and fluids from ingested food, leading to deficiencies in macronutrients like proteins, carbohydrates, and fats, as well as vital micronutrients including essential vitamins and minerals. This complex condition, often arising secondary to chronic gastrointestinal diseases, demands a multifaceted therapeutic approach that combines targeted pharmaceuticals with specialized nutritional support, underlining its significant clinical and economic impact on global healthcare systems. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9520/malabsorption-syndrome-market